The Christie and Holt Radium Institute moved to the present Withington site in 1932 and has grown to be the largest single site cancer hospital in the United Kingdom (UK). The Trust has been designated a separate teaching hospital of the University of Manchester. The Christie became a Foundation Trust in 2007, and serves both the local population across Greater Manchester and Cheshire of 3.2 million people and patients referred from across the UK. Medical and Clinical Oncology consultants work closely together in site-specialised Disease Orientated Groups. They are actively involved in research in joint collaborative programmes in the fields of lymphomas, sarcomas, melanoma, leukaemia, lung, breast, ovary, renal, testis and upper and lower gastrointestinal cancer.
The Manchester Cancer Research Centre (MCRC) was formed in 2006 by The University of Manchester, Cancer Research UK (CRUK) and The Christie. The CRUK Manchester Institute is at the heart of the MCRC. The MCRC brings together basic, translational and clinical researchers to provide a more integrated approach as it is essential to turn findings in the laboratory into more effective treatments for patients with cancer.
The Christie also has its own School of Oncology, enhancing the education and knowledge of healthcare professionals across the country.
The Christie will only accept ‘Residency’ status fellows. This means that GMC accreditation is required. Please view the process necessary for this before applying for an ESO CTC at this centre – https://www.gmc-uk.org/
